Apollo Care, LLC recalls

Apollo Care's semaglutide 20mg injection vials contain visible particles made of nylon/polyamide and silk-like material. The particles were found during quality testing. The affected vials were distributed nationwide.

Apollo Care's semaglutide 10mg injection vials contain visible particles made of nylon, polyamide, and silk-like material. The contamination was identified in lot AC-017274 (expiration 12/12/2026), affecting 500 vials distributed nationwide. No injuries have been reported.

Apollo Care is recalling one lot of semaglutide 7.5mg injection vials due to the presence of particulate matter (nylon/polyamide and silk-type material) in the medication. The contamination was identified during quality testing. No injuries have been reported to date.

Apollo Care's semaglutide 5mg injection vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous material. This contamination affects one lot (AC-017272, expiring 12/12/2026) of approximately 250 vials distributed nationwide. No injuries have been reported.

Apollo Care is recalling one lot of semaglutide injection due to the presence of visible particles identified as nylon/polyamide and silk material in the vials. The contamination was discovered in lot AC-017271 (expiration 12/12/2026). No injuries have been reported.

Apollo Care's semaglutide 0.9mg injectable medication contains visible particles made of nylon, polyamide, and silk-like material. The contamination was found in one lot (AC-017131, expiring 8/30/2026) affecting approximately 4,748 vials distributed nationwide. No injuries have been reported.

Apollo Care's semaglutide injectable medication (a weight-loss drug) contains small particles of nylon and silk-like material in some vials. The affected lots were distributed nationwide. No injuries have been reported.

Apollo Care's semaglutide injection vials contain small particles of nylon/polyamide and silk material. These particles should not be present in a medication injected under the skin. No injuries have been reported.

Apollo Care semaglutide 6.75 mg injection vials contain particulate matter (nylon/polyamide and silk-type material) that should not be present in the medication. The contamination was identified in multiple lot numbers distributed nationwide. No injuries have been reported.

Apollo Care's semaglutide 2.25mg injection vials contain foreign particles made of nylon, polyamide, and silk-like material. The contamination was identified in specific lots distributed nationwide. No injuries have been reported.

Apollo Care's semaglutide 12.5 mg injectable medication was found to contain small particles of nylon/polyamide and silk-like material. The contamination affects multiple lots distributed nationwide. No injuries have been reported.